Back
Taro Pharmaceutical Industries Quote, Financials, Valuation and Earnings

Low-Priced Uranium Stock Poised for 10X Gains as Prices Soar
Learn More Here
Sell
47
TARO
Taro Pharmaceutical Industries
Last Price:
36.02
Seasonality Move:
9.36%
7 Day Trial
ALL ACCESS PASS
$
7

AI SINGULARITY IS 3 MONTHS AWAY
TAKE THESE 3 STEPS NOWTaro Pharmaceutical Industries Price Quote
$36.02
-0.01 (-0.69%)
(Updated: November 29, 2023 at 3:17 AM ET)
Taro Pharmaceutical Industries Key Stats
Sell
47
Taro Pharmaceutical Industries (TARO)
is a Sell
Day range:
$36.00 - $36.59
52-week range:
$22.89 - $42.22
Dividend yield:
0%
P/E ratio:
52.99
P/S ratio:
2.32
P/B ratio:
0.77%
Volume:
33.7K
Avg. volume:
24.6K
1-year change:
29.23%
Market cap:
$1.4B
Revenue:
$573M
EPS:
$0.61
How Much Does Taro Pharmaceutical Industries Make?
-
How Much Are Taro Pharmaceutical Industries's Sales Annually?
TARO Revenues are $573M -
How Much Profit Does Taro Pharmaceutical Industries's Make A Year?
TARO net income is $25.4M
Is Taro Pharmaceutical Industries Growing As A Company?
-
What Is Taro Pharmaceutical Industries's Growth Rate Quarterly?
Quarterly YoY revenue growth is -0.05% -
What Is Taro Pharmaceutical Industries's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is -0.38%
Taro Pharmaceutical Industries Stock Price Performance
-
Did Taro Pharmaceutical Industries Stock Go Up Last Month?
Taro Pharmaceutical Industries share price went up by 9.95% last month -
Did TARO's Share Price Rise Over The Last Year?
TARO share price rose by 29.23% over the past 1 year
What Is Taro Pharmaceutical Industries 52-Week High & Low?
-
What Is Taro Pharmaceutical Industries’s 52-Week High Share Price?
Taro Pharmaceutical Industries has traded as high as $42.22 over the past 52 weeks -
What Is Taro Pharmaceutical Industries’s 52-Week Low Share Price?
Taro Pharmaceutical Industries has traded as low as $22.89 over the past 52 weeks
Taro Pharmaceutical Industries Price To Free Cash Flow
-
Is Taro Pharmaceutical Industries Stock Overvalued?
Taro Pharmaceutical Industries is trading at a price to free cash flow ratio of 5,110.13 -
Is Taro Pharmaceutical Industries Stock Undervalued?
Taro Pharmaceutical Industries EV to Free Cash Flow ratio is 1,687.26 -
What Is Taro Pharmaceutical Industries’s Price Earnings Growth Ratio?
TARO PEG ratio is 0.00 -
Is Taro Pharmaceutical Industries Trading At A Premium To Earnings?
Taro Pharmaceutical Industries EV to EBIT ratio is 0.00
Is It Risky To Buy Taro Pharmaceutical Industries?
-
How Much Debt Does Taro Pharmaceutical Industries Have?
Total long term debt quarterly is $0 -
How Much Cash Does Taro Pharmaceutical Industries Have?
Cash and short term investments quarterly total is $907M -
What Is Taro Pharmaceutical Industries’s Book Value Per Share?
Book value per share is 46.50
Is Taro Pharmaceutical Industries Cash Flow Positive?
Data Unavailable
Taro Pharmaceutical Industries Return On Invested Capital
-
Is Management Doing A Good Job?
TARO return on invested capital is 1.31% -
What Is Taro Pharmaceutical Industries Return On Assets?
ROA measures how assets are converting to revenues and is 1.07% -
What Is TARO Return On Equity?
ROE is a measure of profitability and is 1.31%
Taro Pharmaceutical Industries Earnings Date & Stock Price
-
What Is Taro Pharmaceutical Industries's Stock Price Today?
A single share of TARO can be purchased today for 36.03 -
What Is Taro Pharmaceutical Industries’s Stock Symbol?
Taro Pharmaceutical Industries trades on the nyse under the ticker symbol: TARO -
When Is Taro Pharmaceutical Industries’s Next Earnings Date?
The next quarterly earnings date for Taro Pharmaceutical Industries is scheduled on January 24, 2024 -
When Is TARO's next ex-dividend date?
Taro Pharmaceutical Industries's next ex-dividend date is December 10, 2018 -
How To Buy Taro Pharmaceutical Industries Stock?
You can buy Taro Pharmaceutical Industries shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Taro Pharmaceutical Industries Competitors
-
Who Are Taro Pharmaceutical Industries's Competitors?
Below is a list of companies who compete with Taro Pharmaceutical Industries or are related in some way:
Taro Pharmaceutical Industries Dividend Yield
Data Unavailable
Taro Pharmaceutical Industries Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | -37.84% | 111.11% |
Revenue: | -5.4% | -8.03% |
Analyst Recommendations
Buy Recommendations: | 0 |
---|---|
Hold Recommendations: | 0 |
Sell Recommendations: | 0 |
Price Target: | 35.00 |
Downside from Last Price: | -2.86% |